PPAR-γ Regulates Carnitine Homeostasis and Mitochondrial Function in a Lamb Model of Increased Pulmonary Blood Flow

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Sharma, Shruti ^a   Sun, Xutong ^a   Rafikov, Ruslan ^a   Kumar, Sanjiv ^a   Hou, Yali ^a   Oishi, Peter E ^b   Datar, Sanjeev A ^b   Raff, Gary ^d   Fineman, Jeffrey R ^b,c   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; CARNITINE; CARNITINE ACYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; HEAT SHOCK PROTEIN 90; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENDOTHELIAL DYSFUNCTION; HOMEOSTASIS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LAMB; LUNG BLOOD FLOW; MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CARNITINE; CARNITINE O-ACETYLTRANSFERASE; CARNITINE O-PALMITOYLTRANSFERASE; GENE EXPRESSION REGULATION; HSP90 HEAT-SHOCK PROTEINS; ISOENZYMES; LUNG; MITOCHONDRIA; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PPAR GAMMA; PULMONARY ARTERY; PULMONARY CIRCULATION; SHEEP, DOMESTIC; SIGNAL TRANSDUCTION; SUPEROXIDES; THIAZOLIDINEDIONES; VASODILATOR AGENTS;

OVIS ARIES;

EID: 84866049101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041555     Document Type: Article

References (61)

1. Sharma S, Grobe AC, Wiseman DA, Kumar S, Englaish M, et al. (2007) Lung antioxidant enzymes are regulated by development and increased pulmonary blood flow. Am J Physiol Lung Cell Mol Physiol 293: L960-971.
2. Sharma S, Sud N, Wiseman DA, Carter AL, Kumar S, et al. (2008) Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 294: L46-56.
3. Nisbet RE, Sutliff RL, Hart CM, (2007) The role of peroxisome proliferator-activated receptors in pulmonary vascular disease. PPAR Res 2007: 18797.
4. Kersten S, Desvergne B, Wahli W, (2000) Roles of PPARs in health and disease. Nature 405: 421-424.
5. Vamecq J, Latruffe N, (1999) Medical significance of peroxisome proliferator-activated receptors. Lancet 354: 141-148.
6. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, et al. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92: 1162-1169.
7. Sutliff RL, Kang BY, Hart CM, (2010) PPARgamma as a potential therapeutic target in pulmonary hypertension. Ther Adv Respir Dis 4: 143-160.
8. Tian J, Smith A, Nechtman J, Podolsky R, Aggarwal S, et al. (2009) Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension. Physiol Genomics 40: 48-60.
9. Kleinhenz JM, Kleinhenz DJ, You S, Ritzenthaler JD, Hansen JM, et al. (2009) Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol 297: H1647-1654.
10. Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM, (2005) Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol 25: 1810-1816.
11. Ikejima H, Imanishi T, Tsujioka H, Kuroi A, Kobayashi K, et al. (2008) Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change. J Hypertens 26: 964-972.
12. Bogacka I, Gettys TW, de Jonge L, Nguyen T, Smith JM, et al. (2007) The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue. Diabetes Care 30: 1179-1186.
13. Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, et al. (2000) Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab 85: 4293-4297.
14. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, et al. (1998) Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273: 8560-8563.
15. Kim S, Sohn I, Lee YS, Lee YS, (2005) Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 135: 33-41.
16. Kelly LK, Wedgwood S, Steinhorn RH, Black SM, (2004) Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol 286: L984-991.
17. Wedgwood S, Mitchell CJ, Fineman JR, Black SM, (2003) Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am J Physiol Lung Cell Mol Physiol 284: L650-662.
18. Wedgwood S, Bekker JM, Black SM, (2001) Shear stress regulation of endothelial NOS in fetal pulmonary arterial endothelial cells involves PKC. Am J Physiol Lung Cell Mol Physiol 281: L490-498.
19. Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF, (1981) The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 103: 177-185.
20. Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, et al. (2008) Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 294: C1407-1418.
21. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C, (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197: 40-45.
22. Wiseman DA, Wells SM, Hubbard M, Welker JE, Black SM, (2007) Alterations in zinc homeostasis underlie endothelial cell death induced by oxidative stress from acute exposure to hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 292: L165-177.
23. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, et al. (1995) In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613.
24. Liu J, Killilea DW, Ames BN, (2002) Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci U S A 99: 1876-1881.
25. Sud N, Sharma S, Wiseman DA, Harmon C, Kumar S, et al. (2007) Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 293: L1444-1453.
26. Lakshminrusimha S, Wiseman D, Black SM, Russell JA, Gugino SF, et al. (2007) The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 293: H1491-1497.
27. Marbach EP, Weil MH, (1967) Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. Clin Chem 13: 314-325.
28. Hart CM, (2008) The Role of PPARgamma in pulmonary vascular disease. J Investig Med 56: 518-521.
29. Hart CM, Roman J, Reddy R, Sime PJ, (2008) PPARgamma: a novel molecular target in lung disease. J Investig Med 56: 515-517.
30. Bao Y, Li R, Jiang J, Cai B, Gao J, et al. (2008) Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway. Mol Cell Biochem 317: 189-196.
31. Gupta D, Kono T, Evans-Molina C, (2010) The role of peroxisome proliferator-activated receptor gamma in pancreatic beta cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus. Diabetes Obes Metab 12: 1036-1047.
32. Kim EK, Lee JH, Oh YM, Lee YS, Lee SD, (2010) Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats. Respirology 15: 659-668.
33. Nemenoff R, Meyer AM, Hudish TM, Mozer AB, Snee A, et al. (2008) Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator-activated receptor gamma. Cancer Prev Res (Phila) 1: 349-356.
34. Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, et al. (2009) The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients. Pharmacol Res 60: 519-524.
35. Shen W, Hao J, Feng Z, Tian C, Chen W, et al. (2011) Lipoamide or lipoic acid stimulate mitochondrial biogenesis in 3T3-L1 adipocytes via the endothelial NO synthase-cGMP-protein kinase G signalling pathway. Br J Pharmacol.
36. Viccica G, Francucci CM, Marcocci C, (2010) The role of PPARgamma for the osteoblastic differentiation. J Endocrinol Invest 33: 9-12.
37. Yuen CY, Wong WT, Tian XY, Wong SL, Lau CW, et al. (2011) Telmisartan inhibits vasoconstriction via PPAR{gamma}-dependent expression and activation of endothelial nitric oxide synthase. Cardiovasc Res.
38. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, et al. (2008) An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118: 1846-1857.
39. Tschudi MR, Mesaros S, Lüscher TF, Malinski T, (1996) Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 27: 32-35.
40. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, et al. (2010) Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol 42: 482-490.
41. Kerner J, Hoppel C, (2000) Fatty acid import into mitochondria. Biochim Biophys Acta 1486: 1-17.
42. D'Argenio G, Petillo O, Margarucci S, Torpedine A, Calarco A, et al. (2010) Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis. J Biol Chem 285: 27078-27087.
43. van der Leij FR, Huijkman NC, Boomsma C, Kuipers JR, Bartelds B, (2000) Genomics of the human carnitine acyltransferase genes. Mol Genet Metab 71: 139-153.
44. Sharma S, Sun X, Kumar S, Rafikov R, Aramburo A, et al. (2012) Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. Free Radical Biology and Medicine 53: 216-229.
45. Sun X, Fratz S, Sharma S, Hou Y, Rafikov R, et al. (2011) C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow. American Journal of Respiratory Cell and Molecular Biology 45: 163-171.
46. Poleni PE, Bianchi A, Etienne S, Koufany M, Sebillaud S, et al. (2007) Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes. Osteoarthritis Cartilage 15: 493-505.
47. Mata-Greenwood E, Meyrick B, Steinhorn RH, Fineman JR, Black SM, (2003) Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 285: L209-221.
48. Liu Y, Zhu Y, Rannou F, Lee TS, Formentin K, et al. (2004) Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells. Circulation 110: 1128-1133.
49. Liu Y, Zhang Y, Schmelzer K, Lee TS, Fang X, et al. (2005) The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci U S A 102: 16747-16752.
50. Konduri GG, Mattei J, (2002) Role of oxidative phosphorylation and ATP release in mediating birth-related pulmonary vasodilation in fetal lambs. Am J Physiol Heart Circ Physiol 283: H1600-1608.
51. Konduri GG, Mital S, (2000) Adenosine and ATP cause nitric oxide-dependent pulmonary vasodilation in fetal lambs. Biol Neonate 78: 220-229.
52. Brouet A, Sonveaux P, Dessy C, Balligand JL, Feron O, (2001) Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem 276: 32663-32669.
53. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, et al. (2002) Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873.
54. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, et al. (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824.
55. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, et al. (2000) Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. Journal of Biological Chemistry 275: 22268-22272.
56. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, et al. (2001) Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276: 17621-17624.
57. Hashimoto R, Umemoto S, Guo F, Umeji K, Itoh S, et al. (2010) Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP. J Atheroscler Thromb 17: 785-795.
58. Dhaunsi GS, Yousif MH, Akhtar S, Chappell MC, Diz DI, et al. (2010) Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol 638: 108-114.
59. Ewing JF, Janero DR, (1998) Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection. Free Radic Biol Med 25: 621-628.
60. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE, (1993) Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A 90: 8103-8107.
61. Stamler JS, Singel DJ, Loscalzo J, (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902.